Surface modification of hydrophobic membranes

Porous polymer membranes with fluorine-containing monomer surface treatments address pore blockage, mechanical instability, and regulatory concerns, achieving enhanced hydrophobicity and air flow, suitable for filtration.

JP2024541212AActive Publication Date: 2024-11-08EMD MILLIPORE CORP
View PDF 11 Cites 0 Cited by

Patent Information

Application Number
JP2024523666
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-02
Filing Date
2022-11-07
Publication Date
2024-11-08
Estimated Expiration
2042-11-07

AI Technical Summary

Technical Problem

Existing hydrophobic membranes, particularly those made from polytetrafluoroethylene (PTFE), face issues such as pore blockage due to condensation, mechanical instability under ionizing radiation, and chemical sterilization challenges, leading to reduced mechanical strength and permeability, with regulatory concerns over certain surface treatments like perfluoroalkyl substances (PFAS).

Method used

Development of porous polymer membranes with surface modifications using fluorine-containing monomers and crosslinkers, such as dodecane acrylate (DDA19), which are polymerized and cross-linked to create a hydrophobic surface, avoiding PFAS molecules of C6 carbon chain length or longer, ensuring regulatory compliance and maintaining mechanical strength.

Benefits of technology

The membranes achieve enhanced hydrophobicity, improved air flow, and resistance to sterilizing radiation, while meeting regulatory standards, maintaining mechanical strength and avoiding PFAS-related issues, suitable for filtration applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024541212000001_ABST
    Figure 2024541212000001_ABST
Patent Text Reader

Abstract

1. A porous polymer membrane comprising a porous membrane having an average pore size between about 0.001-10.0 microns formed with a first polymer, the substrate having a surface modified with a crosslinked second polymer formed from a polymerizable fluorine-containing monomer containing continuous chains of 5 or less carbon atoms along with fluorine atoms, the monomer being polymerized and crosslinked on the membrane, the membrane containing less than 25 ppb of C6PFCA (perfluorocarboxylic acid), less than 25 ppb of C8PFCA, and less than 25 ppb of combined C9-14PFCA.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] This application claims the benefit of priority to US Provisional Application No. 63 / 285,322, filed December 2, 2021, which is incorporated by reference in its entirety.

[0002] This application relates to membranes for use in the life sciences industry. In particular, embodiments of the technology disclosed herein relate to hydrophobic membranes useful in filtration applications.

[0003] The present disclosure relates to membranes, such as porous membranes, that further comprise a hydrophobic surface. More specifically, the present disclosure relates to microporous or ultrafiltration membranes that have been modified to produce a hydrophobic surface, including the membrane pore surfaces, and processes for forming such membranes. [Background technology]

[0004] Polytetrafluoroethylene (PTFE) is a material commonly used for membranes in devices used to vent gases. The chemical and biological inertness, thermal stability, and hydrophobicity inherently associated with PTFE have led to the development of PTFE as the material of choice in industrial gas vent applications. PTFE membranes are also widely used in health and related industries. The need to produce sterile vent membranes for use in medical / biological devices has also naturally led to the selection of PTFE as the material of choice in membrane applications. Traditionally, sterile materials have been produced by chemical sterilization, particularly by steam treatment, gamma irradiation, or treatment with ethylene oxide. The compatibility of PTFE with sterilizing chemicals and treatments, especially at elevated temperatures, is a known material property characteristic of PTFE. A problem with the use of PTFE as a vent membrane material under steam treatment is the clogging of the pores due to condensation of oil, or water, or both, from the machinery used to generate the steam. The resulting loss of air permeability of the clogged membrane effectively reduces the membrane's usefulness as a gas vent. This condensation problem has led to the search for and development of more hydrophobic and oleophobic membrane materials as alternatives to PTFE. A more serious problem concerns chemical sterilization of membrane materials for use under aseptic conditions. Chemical sterilization, especially with ethylene oxide, very often results in additional problems such as toxicity and waste disposal, which raises serious health, environmental and economic concerns. These concerns have led to the widespread use of ionizing radiation for sterilization of materials used in medical and biological devices. The main drawback of PTFE is its inherent instability to ionizing radiation. Ionizing irradiation of PTFE membranes results in the undesirable property of reduced mechanical strength. This loss of mechanical strength imposes serious limitations on the use of PTFE membranes under moderate pressures.

[0005] Attempts to solve these shortcomings of irradiation have included the use of coatings placed on the membrane. Coatings of material allow for the retention of desirable bulk material properties while only changing the surface and interfacial properties of the membrane substrate. Hydrophobic and oleophobic coatings are used in the electronics industry as protective barriers for electronic components. However, coating membranes has not been a practical approach to modifying the membrane's surface properties because the tortuous morphology associated with membranes rarely results in a continuous coating. Furthermore, because the coating is not permanently fixed (bonded) to the underlying substrate, the coated material is very often susceptible to abrasion, such as delamination. Also, organic coatings can produce extractables that can harm biological products. Each of these failure conditions exhibits a limited range of thermal and chemical compatibility. In addition, coatings adversely affect the permeability properties of the porous substrate, such as flux.

[0006] It has also been proposed to use grafting technology to modify the surface properties of polymer substrates.Typical examples of grafting technology are shown in, for example, U.S. Patent Nos. 3,253,057, 4,151,225, 4,278,777 and 4,311,573.The grafting technology for modifying the surface properties of porous membranes presents manufacturing problems, such as the difficulty of modifying the entire surface of the membrane, including the surface within the pores, while avoiding pore blockage and maintaining the porosity of the membrane.

[0007] In U.S. Patent No. 4,954,256, it was proposed to make the surface of a microporous polymer membrane more hydrophobic by grafting a fluoropolymer onto the membrane surface to chemically bond the fluoropolymer to the membrane surface. The fluoropolymer is formed from a monomer containing an ethylenically unsaturated group and a fluoroalkyl group. The grafting is carried out by exposing the membrane in a monomer solution to ionizing radiation. A typical ionizing radiation source is a cobalt-60 gamma radiation source. The fluoropolymer formed from the fluorine-containing ethylenically unsaturated monomer is permanently bonded to the microporous membrane substrate.

[0008] Other prior art attempts disclose a process for preparing hydrophobic / oleophobic membranes that does not include surface modification. Rather, it is an in-situ process in which, thanks to phase separation, both the underlying substrate and the hydrophobic surface of the membrane are simultaneously formed by a photopolymerization process. The resulting membrane is mechanically weak and needs to be supported / laminated for use as a venting membrane under relatively moderate pressure. Furthermore, this process results in membranes with a relatively narrow range of properties, since the membrane morphology and surface properties are formed simultaneously. Another prior art attempt discloses a process for preparing hydrophobic and oleophobic porous substrates, which involves impregnating a porous substrate with a solution of fluorinated monomers in a carrier solvent, removing the solvent by evaporation, and then polymerizing the remaining monomers. This process is a solid-state polymerization reaction.

[0009] Another approach involves a porous membrane substrate having a crosslinked polymerizable monomer composition coated on the substrate, as disclosed, for example, in U.S. Pat. Nos. 4,618,533 and 5,286,382. The monomer composition includes a polymerizable monomer and a crosslinking agent for the monomer. Conventional energy sources for initiating free radical polymerization can be used to form a crosslinked polymer coating on the porous membrane in situ, such as ultraviolet (UV) light or heat. This produces a membrane surface-modified with a crosslinked polymer. There is no mention in U.S. Pat. No. 4,618,533 of forming a crosslinked modified surface from an ethylenically unsaturated monomer having a fluoroalkyl group. However, an ethylenically unsaturated monomer having a fluoroalkyl group is disclosed in U.S. Pat. No. 5,286,382.

[0010] U.S. Patent No. 5,037,457 discloses a means for enhancing the mechanical strength of gamma-irradiated PTFE membranes by laminating the PTFE membrane to a porous polyester web. This approach solves the problems associated with the mechanical stability of gamma-irradiated PTFE. The chemical compatibility of the laminated membrane is limited by the properties of the porous web support. Furthermore, laminates, especially those formed by the use of adhesives that are often sensitive to gamma radiation, are prone to delamination.

[0011] Superhydrophobic membranes can be produced by surface modification of cast hydrophobic PVDF (DURAPORE®) and hydrophobic PES (EXPRESS®) membranes, both of which are commercially available from EMD Millipore Corporation (Burlington, Massachusetts, USA). PVDF membranes with several pore sizes, e.g., 0.1, 0.2, 0.45, 0.65, 1, 5 microns (μm) and one pore size (0.2 μm), and PES membranes with superhydrophobicity have been commercially available for several years. The superhydrophobic modification is performed by polymerizing and crosslinking fluorocarbon-containing molecules on the membrane surface. Such membranes are frequently used in air filtration applications.

[0012] At least one monomer used to make the membrane's surface superhydrophobic is called perfluorooctylethyl acrylate (POEA). This chemical falls into a list of chemicals commonly called PFAS (perfluoroalkyl substances) and was banned by ECHA (European Chemicals Agency) under the REACH program (Registration, Evaluation, Authorization and Restriction of Chemicals). Attempts were made to replace POEA with PDA (1H,1H-perfluoro-n-decyl acrylate). However, PDA was also under regulation. Regulatory agencies also continue to focus on PFAS and impose strict threshold limits on impurity levels of degradation products as well as potential degradation products associated with these PFAS, which are generally 25 parts per billion (PPB).

[0013] Perfluorocarboxylic acids (PFCAs), both linear and branched, are being considered for use. However, C9-C14 PFCAs are subject to regulation and should not be manufactured or placed on the market as substances by themselves, or used in the manufacture of or placed on the market (a) as a constituent of another substance, (b) a mixture, or (c) an article at a concentration of more than 25 parts per billion (PPB) for the sum of C9-C14 PFCAs and their salts, or 260 PPB for the sum of C9-C14 PFCAs-related substances. Perfluorocarboxylic acids (linear and / or branched), their salts and PFCAs related substances, namely: (a) perfluorocarboxylic acids having the following formula: CnF2n+1-C(=O)OH (n=8, 9, 10, 11, 12 or 13), including their salts and any combinations thereof; (b) any PFCAs related substances having a perfluoro group of the formula CnF2n+1 (wherein n=8, 9, 10, 11, 12 or 13), which is directly bonded to another carbon atom, including any combinations thereof; (c) any PFCAs related substances having a perfluoro group of the formula CnF2n+1 (wherein n=9, 10, 11, 12, 13 or 14), which is not directly bonded to another carbon atom as one of the structural elements, including any combinations thereof. The following materials are excluded from this designation: (a) CnF2n+1-X, where X=F, Cl or Br, where n=9, 10, 11, 12, 13 or 14, including any combination thereof; (b) CnF2n+1-C(=O)OX', where n>13 and X'=any group, including salts.

[0014] Undecafluorohexanoic acid (PFHxA), its salts and related substances are also highly regulated. PFHxA may not be manufactured, used or marketed as a substance by itself. The following should also not be used or marketed: (a) as a constituent of another substance, (b) in a mixture, or (c) in an article, at a concentration of 25 PPB or more for the sum of PFHxA and its salts, or 1000 PPB for the sum of PFHxA-related substances: (a) any PFHxA-related substance (including its salts and polymers) having a linear or branched perfluoropentyl group with the formula C5F11- directly attached to another carbon atom, (b) any PFHxA-related substance (including its salts and polymers) having a linear or branched perfluorohexyl group with the formula C6F13-. The following materials are excluded from this formula: (a) C6F13-X (where X=F); (b) C6F13-C(=O)OH, C6F13-C(=O)O-X', or C6F13-CF2-X' (X'=any group, including salts).

[0015] In view of the above, a monomeric alternative to POEA for an unregulated surface treatment of porous membranes would represent an advance in the art. A porous membrane that is as hydrophobic and / or more hydrophobic than currently available membranes and has an unregulated surface treatment would represent an advance in the art. Additionally, a membrane with a surface treatment that retains its mechanical strength after exposure to sterilizing ionizing radiation and does not degrade to PFOA upon environmental and other degradation would represent an advance in the art. A C5 monomer for use with a crosslinker to create an environmentally friendly surface treatment for membranes would represent an advance in the art. [Prior art documents] [Patent documents]

[0016] [Patent Document 1] U.S. Pat. No. 3,253,057 [Patent Document 2] U.S. Pat. No. 4,151,225 [Patent Document 3] U.S. Pat. No. 4,278,777 [Patent Document 4] U.S. Pat. No. 4,311,573 [Patent Document 5] U.S. Pat. No. 4,954,256 [Patent Document 6] U.S. Pat. No. 4,618,533 [Patent Document 7] U.S. Pat. No. 5,286,382 [Patent Document 8] U.S. Pat. No. 5,037,457 Summary of the Invention

[0017] Embodiments of the present disclosure include a porous polymeric membrane comprising a porous membrane having an average pore size of about 0.001-10 microns formed with a first polymer, said substrate having a surface modified on its surface with a crosslinked second polymer formed from a polymerizable fluorine-containing monomer containing a continuous chain of 5 or less carbon atoms ("C5") with fluorine atoms, said monomer being polymerized and crosslinked on said membrane, said membrane comprising less than 25 ppb of C6 PFCAs (perfluorocarboxylic acids), less than 25 ppb of C8 PFCAs and less than 25 ppb of combined C9-14 PFCAs, substantially as shown and / or described in connection with at least one of the figures and fully described in the claims. The novel and inventive features of the present disclosure, as well as details of exemplary embodiments thereof, will be more fully understood from the following description and drawings. The novel approach for both the monomers and crosslinkers avoided the use of any PFAS molecules with a C6 carbon chain length or greater to meet regulatory requirements. Approximately 15 monomers were sourced and screened in the laboratory with both PVDF and PES based membranes. Three performance characteristics were measured: 1) surface energy (a measure of hydrophobicity), 2) air flow, and 3) water entry pressure. Some of the new monomers had surface energies of 25 mJ / m 2 could be reduced to less than 19 mJ / m 2A target surface energy of less than 100 nm could be achieved. The monomer DDA19 is a dodecane acrylate containing 19 fluorine atoms. Surface chemistry targets and methods according to some embodiments of the present disclosure include a series of fluorinated functional acrylates / allyls (referred to as monomers) and difunctional acrylates (referred to as crosslinkers) that have been investigated using surface modification chemistries as described herein.

[0018] In some embodiments, the PVDF or PES membrane comprises pores of any suitable size for various filtration applications, as known to those skilled in the art. In some embodiments, the membrane comprises pores of 0.001 to 10.0 microns. In some embodiments, the membrane comprises pores of 0.01 to 5.0 microns. In some embodiments, the membrane comprises pores of 0.05 to 1 microns. In some embodiments, the membrane comprises pores of 0.1 to 0.22 microns. In some embodiments, the membrane comprises pores of about 0.2 to 0.45 microns. Also, in some embodiments, the substrate comprises a woven or nonwoven material. For example, suitable substrates include polyethylene, polypropylene, nylon, and other suitable polyolefins and / or polyamides.

[0019] These and other advances embodied herein will become apparent from the following description, claims, and drawings. Various benefits, aspects, novel and inventive features of the present disclosure, as well as details of exemplary embodiments of the coated membrane and the vent filtration device comprising the coated membrane, will be more fully understood from the following description and drawings. The embodiments of the present disclosure include a porous polymer membrane that can be incorporated into a filter unit to facilitate ventilation of air or gas. Thus, a more specific description of the embodiments of the present disclosure, briefly summarized above, in a manner in which the features disclosed herein may be understood in detail, can be obtained by referring to the accompanying drawings. However, it should be noted that the accompanying drawings show only typical embodiments of the present disclosure, and thus the described embodiments should not be considered as limiting its scope, since other equally effective surface treatments, methods, and / or materials may be tolerated. It should also be understood that elements and features of one embodiment can be found in other embodiments without further elaboration, and that the same reference numbers, where possible, have been used to indicate equivalent elements common to the drawings. As used herein, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which these embodiments pertain.

[0020] A surface is considered to be hydrophobic when its static water contact angle θ is >90° and generally hydrophilic when θ is <90°. Superphobic (superhydrophobic) is defined herein as having a static water contact angle θ of about >150°.

[0021] Membrane surface modification or treatment is defined as a chemical process to obtain surface properties, such as hydrophobicity, while retaining bulk membrane properties such as mechanical and chemical resistance, morphology, pore size, etc. [Brief description of the drawings]

[0022] [Figure 1] 1 shows a flowchart of a method for making a coated membrane according to some embodiments of the present disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0023] The embodiments of the present disclosure include polyethersulfone (PES) and / or polyvinylidene fluoride (PVDF) membranes having surface modification with various short chain fluorocarbon acrylic or allyl-based molecules. PES and PVDF membranes having the above surface treatments have shown a significant increase in the superhydrophobicity of the membrane surface. The membrane embodiments discussed herein are often used for various air filtration applications. The surface treatment step was achieved by polymerization of acrylate molecules followed by crosslinking with diacrylate molecules under an electron beam or ultraviolet (UV) energy source. The enhanced superhydrophobic performance shown here is measured as surface energy. It should be understood that in some embodiments, the PES or PVDF membranes include pore sizes of any size suitable for various filtration applications as known to those skilled in the art. In some embodiments, the membranes include pore sizes of 0.001 to 10.0 microns. In some embodiments, the membranes include pore sizes of 0.01 to 5.0 microns. In some embodiments, the membranes include pore sizes of 0.05 to 1 microns. In some embodiments, the membrane comprises a pore size of 0.1 to 0.22 microns. In some embodiments, the membrane comprises a pore size of about 0.2 to 0.45 microns. Also, in some embodiments, the substrate comprises a woven or nonwoven material. For example, suitable substrates include polyethylene, polypropylene nylon, and other suitable polyolefins and / or polyamides. Any of these membranes and substrates may be treated with the surface treatments discussed herein to produce porous polymeric membranes for filtration applications.

[0024] The novel approach for both monomers and crosslinkers avoided the use of any PFAS molecules with a C6 carbon chain length or greater to meet regulatory requirements. Approximately 15 monomers were sourced and screened in the lab with both PVDF and PES based membranes. Three performance characteristics were measured: 1) surface energy (a measure of hydrophobicity), 2) air flow, and 3) water entry pressure. Some of the new monomers had surface energies of 25 mJ / m 2 could be reduced to less than 19 mJ / m 2 The target energy of less than 100 nm could be achieved. The monomer DDA19 shown is a dodecane acrylate containing 19 fluorine atoms.

[0025] Surface chemistry targets and methods according to some embodiments of the present disclosure include a series of fluorinated functional acrylates / allyls (referred to as monomers) and difunctional acrylates (referred to as crosslinkers) that have been investigated using surface modification chemistries as described herein.

[0026] Table 3 shows the millijoules per square meter of surface energy (mJ / m), a measure of the superhydrophobicity of the membrane surface, for the various chemical solutions / mixtures investigated as surface treatments for the various membranes. 2 ) will be disclosed.

[0027] Table 4 discloses the surface energy of the current superhydrophobic chemistry (POEA chemistry). Different chemical formulations were identified from a series of studies conducted at different formulation conditions. A UV source was used as the energy source to initiate the polymerization and crosslinking steps. It is contemplated herein that other sources, chemical sources, and other energy sources may be used to initiate the polymerization and / or crosslinking process.

[0028] [Table 1] TIFF2024541212000003.tif213161

[0029] [Table 2]

[0030] [Table 3]

[0031] [Table 4]

[0032] Table 5 discloses the various chemistries used and a comparison of membrane performance (surface energy, air flow and water entry pressure) of the current (POEA) and novel DDA19 chemistries.

[0033] DDA19 is the name of the monomer of dodecane acrylate containing 19 fluorine groups. The chemical structure of 2-propenoic acid, 3,3,4,4,5,5,6,6,7,7,9,9,10,10,11,11,12,12,12-nonadecafluorododecyl ester (DDA19) may include the following:

[0034] [ka]

[0035] [Table 5]

[0036] Table 6 provides an overview of formulations according to some embodiments of the present disclosure.

[0037] [Table 6] TIFF2024541212000010.tif62165

[0038] Table 7 shows pre-gamma and post-gamma treatment of membranes with the new coating containing less than 25 ppb C6 PFCAs (perfluorocarboxylic acids), less than 25 ppb C8 PFCAs, and less than 25 ppb combined C9-14 PFCAs. The values ​​shown in Table 7 (shown in nanograms / gram) vary from lot to lot, but are not substantial, e.g., less than 25 PPB.

[0039] [Table 7]

[0040] [Table 8]

[0041] Polymerization and cross-linking of the polymerizable monomer onto the porous membrane substrate is carried out using a reagent bath such that the surfaces of the porous membrane, including the inner surface of the porous membrane, are coated with the cross-linked polymer.

[0042] A reagent bath containing (1) a polymerizable monomer that is ethylenically unsaturated and has at least one fluoroalkyl group, (2) optionally a polymerization initiator, and (3) a crosslinking agent in a solvent for the three reagents, is contacted with the porous membrane substrate under conditions that result in polymerization of the monomer and deposition of the resulting crosslinked polymer on the porous membrane substrate.

[0043] FIG. 1 shows a flow chart of a method 100 for making a coated film according to some embodiments of the present disclosure. In step 102 of the method 100, a solution is made. For example, a polymer solution includes making a chemical solution / mixture of a monomer (e.g., DDA19) and a crosslinker (e.g., HDDA) in a DMTS solvent with an initiator (e.g., DMPA / I651). I651 is a photoinitiator having CAS#24650-42-8, commercially available as IRGACURE by Ciba Corp., New York, USA. Many initiators can be used in some embodiments within the present disclosure.

[0044] In step 104, a membrane is prepared, which may be an asymmetric or symmetric membrane. The membrane may also be a PES or PVDF membrane. One way to prepare the membrane is to prepare a membrane sheet for coating with the chemical solution / mixture from step 102. For example, cut a basement membrane of the desired size (e.g., 5 inches by 3 inches) for either PVDF and PES.

[0045] In step 106, the chemical solution / mixture is applied to the membrane surface. Application of the chemical solution / mixture can be done either by immersing the membrane sheet in the chemical mixture solution in a tray, e.g., a glass tray, or by placing the chemical solution / mixture directly onto the membrane surface (in some embodiments, the wet membrane surface), e.g., using a pipette or other delivery means.

[0046] In step 108, the membrane sheet with the chemical solution / mixture is exposed to an energy source, for example, a UV / electron beam source for a polymerization reaction, producing a polymer coating on the membrane surface.

[0047] In step 110, a washing step is used to remove any unreacted chemical solution / mixture using a solvent (eg, methanol and water).

[0048] In step 112, a drying step is used to dry the cleaned film (eg, at 100° C. for 15 minutes). The method 100 ends after step 112.

[0049] It has been found that by selecting an appropriate solvent system, the hydrophobicity of the membrane having the surface treatment can be controlled so that the coated membrane is not wetted by solvents having a surface tension greater than about 21 dynes / cm. Many such solvent systems are available. One such suitable solvent for use with embodiments according to the present disclosure is decamethyltetrasiloxane (DMTS). Another monomer is 1H,1H-perfluoro-3,6,9-trioxatridecan-1-ol acrylate (PTTA). The common name of the initiator I651 is 2,2-dimethoxy-2-phenylacetophenone (DMPA).

[0050] When utilizing fluorine-containing polymerizable monomer with unsaturation degree of more than 1, there is no need to add additional monomer in the coating of the present disclosure.Three reactants, for example, polymerizable monomer, polymerization initiator and crosslinker, are contacted with porous membrane as a mixture in a solvent compatible with these three reactants and porous membrane, so that desired free radical polymerization and crosslinking are achieved without forming a significant amount of slowly extractable by-products.If easily extractable by-products are formed, they can be removed by performing a washing step with a suitable solvent after the coating step.

[0051] Generally, the polymerizable monomer is present in the reactant solution at a concentration between about 2% and about 20%. In some embodiments, between about 2.5% and 7.5% based on the weight of the polymerizable monomer. The crosslinker is present in an amount between about 0.5% and about 5% by weight based on the weight of the polymerizable monomer. The polymerization initiator is present in an amount between about 0.1% and about 1% by weight based on the weight of the polymerizable monomer. In some embodiments, the initiator is present in an amount between about 0.15% and 0.17%. The crosslinker is available without monomer and therefore functions as a polymerizable monomer.

[0052] Polymerization and crosslinking can be accomplished by exposing the monomer reaction system to ultraviolet (UV) light, a heat source, and / or ionizing radiation. Because it is rapid, embodiments of the present disclosure include using UV light. The process involves immersing the membrane substrate in a solution containing monomers, crosslinking agents, and initiators, placing the membrane between two UV-transparent sheets, such as polyethylene, and exposing the sandwich to UV light. The process can be performed continuously, and the desired crosslinked coating is formed within minutes after UV exposure begins. By controlling the reactant concentrations and UV exposure as described above, the plug is pulled and a composite is produced that has the same porous configuration as the membrane substrate. Furthermore, the composite membrane produced is wettable only by solvents with a surface tension of less than about 21 dynes / cm. That is, the composite and / or coated membrane of the present disclosure has a highly hydrophobic surface. The composite and / or coated membrane of the present disclosure also retain their mechanical strength even after exposure to sterilizing ionizing radiation.

[0053] The composites of the present disclosure can withstand at least 10 PSI forward or reverse pressure after being sterilized by exposure to gamma radiation, typically between about 2-5 megarads. In addition, the sterile membrane composites of the present disclosure retain a desirable degree of hydrophobicity so that they are not wetted by aqueous solutions, including solutions containing surfactants. The composites are useful as gas vents to selectively allow gas to pass while preventing the passage of organic and aqueous liquids, such as in the devices described in U.S. Pat. No. 3,854,907, which is incorporated herein by reference. An embodiment of the present disclosure includes a membrane suitable for use in a filtration device. The membrane is a hydrophobic membrane incorporated into a filtration device that allows gas to be selectively vented, i.e., impermeable to aqueous solutions, such as when an aqueous solution is filtered through a hydrophilic filter prior to intravenous administration. As an integral part of the filtration device, the membrane remains hydrophobic, i.e., not wetted by aqueous solutions, in its functional use as a gas vent membrane and incorporation into a vent filter device.

[0054] Some embodiments of the present disclosure are contemplated herein including a porous polymeric membrane having a surface treatment disposed thereon, the surface treatment containing less than 25 ppb of C6PFCA (perfluorocarboxylic acid), less than 25 ppb of C8PFCA, and less than 25 ppb of combined C9-14PFCA upon exposure to gamma radiation up to 50 kGy.

[0055] Porous polymeric membranes according to some embodiments of the present disclosure include polyvinylidene fluoride, nylon, polyamide, polyimide, polyethersulfone, polysulfone, polyarylsulfone, cellulose, regenerated cellulose, cellulose esters, acrylic polymers, methacrylic polymers, copolymer acrylic methacrylic polymers, and combinations thereof.

[0056] The water intrusion test approach is a "pressurized" wettability / adsorption test that allows for indirect evaluation of the hydrophobicity of the inner surface of a porous membrane. This pressurized wettability / adsorption approach can be extended in its usefulness to solutions other than aqueous nutrient mixtures to evaluate membrane performance under various operating (e.g., aeration) conditions.

[0057] All ranges of the compositions listed herein include the ranges therebetween and may include or exclude the endpoints. Optionally included ranges are derived from the integer values ​​therebetween (or including one original endpoint) at the recited order of magnitude or the next smaller order of magnitude. For example, if the lower limit is 0.2, the optionally included endpoints can be 0.3, 0.4, ... 1.1, 1.2, etc., as well as 1, 2, 3, etc., and if the upper range is 8, the optionally included endpoints can be 7, 6, etc., as well as 7.9, 7.8, etc. One-sided limits such as 3 or greater similarly include consistent limits (or ranges) starting from the recited order of magnitude or one lower integer value. For example, 3 or greater includes 4 or 3.1 or greater.

[0058] Throughout this specification, reference to "one embodiment," "a particular embodiment," "one or more embodiments," "some embodiments," or "an embodiment" indicates that a feature, structure, material, or characteristic described in connection with that embodiment is included in at least one embodiment of the disclosure. Thus, appearances of phrases such as "in one or more embodiments," "a particular embodiment," "in one embodiment," "some embodiments," or "in an embodiment" throughout this specification do not necessarily refer to the same embodiments.

[0059] Although some embodiments have been discussed above, other implementations and applications are also within the scope of the following claims. Although the present specification has been described with reference to certain embodiments, it should be understood that these embodiments are merely illustrative of the principles and applications of the present disclosure. Thus, it should be further understood that numerous modifications can be made to the exemplary embodiments and other configurations and patterns can be devised without departing from the spirit and scope of the embodiments in accordance with the present disclosure. Furthermore, the particular features, structures, materials, or characteristics may be combined in any suitable manner in any one or more of the embodiments.

[0060] The patent applications and patent documents, as well as non-patent references, cited herein are hereby incorporated by reference in their entirety in the entirety as if each individual publication or reference was specifically and individually indicated to be incorporated herein by reference as if fully set forth herein. Any patent application to which this application claims priority is also incorporated by reference herein in the manner described above for publications and references.

Claims

1. 1. A porous polymer membrane comprising: 0.001 to 10.0 microns formed from a first polymer; or 0.01 to 5.0 microns, or Between 0.05 and 1 micron, or Between 0.1 and 0.22 microns, or Between 0.2 and 0.45 microns a porous membrane having an average pore size of The porous polymer membrane has a surface modified with a polymerizable fluorine-containing monomer containing continuous chains of 5 or less carbon atoms along with fluorine atoms, the monomer being polymerized and crosslinked on the membrane, the membrane containing less than 25 ppb of C6 PFCA (perfluorocarboxylic acid), less than 25 ppb of C8 PFCA and less than 25 ppb of combined C9-14 PFCA.

2. 10. The porous polymeric membrane of claim 1, containing less than 25 ppb C6 PFCA (perfluorocarboxylic acid), less than 25 ppb C8 PFCA, and less than 25 ppb combined C9-14 PFCA after exposure to up to 50 kGy of gamma radiation.

3. 10. The porous polymeric membrane of claim 1, wherein the first polymer comprises polyvinylidene fluoride, nylon, polyamide, polyimide, polyethersulfone, polysulfone, polyarylsulfone, cellulose, regenerated cellulose, cellulose esters, acrylic polymers, methacrylic polymers, copolymeric acrylic methacrylic polymers, and combinations thereof.

4. 10. The porous polymeric membrane of claim 1 which is an asymmetric or symmetric membrane.

5. 10. The porous polymeric membrane of claim 1 comprising a polyvinylidene fluoride membrane or a polyethersulfone membrane.

6. 10. The porous polymeric membrane of claim 1, capable of being incorporated into a filter unit to facilitate ventilation of air or gas.

7. 1. A porous polymeric membrane having a surface treatment, comprising a porous membrane having an average pore size between about 0.001 and 0.22 microns formed with a first polymer, said porous membrane having a surface modified thereon with a crosslinked second polymer, said crosslinked second polymer further comprising between 3.2% and 4.4% by weight of a fluorinated acrylate and 0.66 to 0.89 of 1,6-hexanediol diacrylate.

8. 1. A porous polymeric membrane having a surface treatment, comprising a porous membrane having an average pore size between about 0.001 and 0.22 microns formed with a first polymer, said porous membrane having a surface modified thereon with a crosslinked second polymer, said crosslinked second polymer further comprising between 2.6% and 4.4% by weight of a fluorinated acrylate and 0.60 to 1.15 of 1,6-hexanediol diacrylate.

9. The porous polymer membrane with surface treatment according to claims 7-8, wherein the crosslinked second polymer further comprises between 0.15-0.17% of an initiator.

10. The porous polymer membrane with a surface treatment according to claims 7-8, wherein the crosslinked second polymer further comprises 0.15-0.17% of 2,2-dimethoxy-2-phenylacetophenone.

11. 9. The porous polymer membrane having a surface treatment according to claim 7-8, wherein the first polymer comprises polyvinylidene fluoride, nylon, polyamide, polyimide, polyethersulfone, polysulfone, polyarylsulfone, cellulose, regenerated cellulose, cellulose ester, acrylic polymer, methacrylic polymer, copolymer acrylic methacrylic polymer, and combinations thereof.

12. The porous polymer membrane with surface treatment according to claims 7 to 8, which is an asymmetric membrane or a symmetric membrane.

13. The porous polymer membrane having a surface treatment according to claims 7 to 8, comprising a polyvinylidene fluoride membrane or a polyethersulfone membrane.

14. A porous polymer membrane with a surface treatment according to claims 7-8, which can be incorporated into a filter unit to facilitate the ventilation of air or gas.

15. The porous polymer membrane having a surface treatment according to claims 7 to 8, further comprising decamethyltetrasiloxane as a solvent.

16. 1. A method for providing a polymeric surface treatment to a membrane, comprising the steps of: preparing a polymer solution comprising a monomer, a crosslinker, and an initiator in a solvent; applying the polymer solution to a PES or PVDF membrane; exposing the membrane with the polymer solution applied to the membrane to an energy source; and drying the polymer solution, wherein the monomer is a fluorinated monomer and the initiator is a photoinitiator.

17. 16. The method of claim 15, wherein the membrane is an asymmetric or symmetric membrane and the applying step is a coating step of immersing the membrane in a tray of the polymer solution or placing the polymer solution directly onto the membrane using a pipette.

18. 16. The method of claim 15, wherein the fluorinated monomer is 2-propenoic acid, 3,3,4,4,5,5,6,6,7,7,9,9,10,10,11,11,12,12,12-nonadecafluorododecyl ester.

19. The method of claim 15, wherein the crosslinker is a diacrylate.

20. The method of claim 15, wherein the crosslinking agent is 1,6-hexanediol diacrylate or octafluorohexyl diacrylate.

Citation Information

Patent Citations

  • In order to obtain an improved water repellency and porous substrate processing method

    JP1992506982A

  • Hydrophobic composite polymer membrane

    JP1994009810A

  • Gas separating membrane and composite membrane, their manufacturing method, module using the same and separator

    JP2011041938A

  • Treatment of fluorinated polymers and products obtained thereby

    US3253057A

  • Method for the modification of polyvinylidene fluoride

    US4151225A